Inventor · disambiguated record
Andrew P. Mazar
Also filed as: MAZAR ANDREW · MAZAR ANDREW P
16 granted patents·19 pending applications·164 citations·filing 1997–2024
93Inventor score
Files withANGSTROM PHARMACEUTICALS INC7ATTENUON LLC6ACTUATE THERAPEUTICS INC4MAZAR ANDREW P2NORTHSTAR MEDICAL TECH LLC2
Top patents by PatentIndex Score
35 records- 0195US7807621B2Anti-invasive and anti-angiogenic compositionsANGSTROM PHARMACEUTICALS INC·Filed 2006·Granted Oct 5, 2010·34 cites·1 claims
- 0291US11980607B2Methods of treating malignant lymphoproliferative disordersACTUATE THERAPEUTICS INC·Filed 2022·Granted May 14, 2024·1 cites·17 claims
- 0385US8101726B2Ligands binding the complex of urokinase-type plasminogen activator (uPA) and its receptor (uPAR) that inhibit downstream uPAR interactions: identification and use in diagnosis or therapyPARRY GRAHAM C·Filed 2005·Granted Jan 24, 2012·14 cites·27 claims
- 0482US6896870B1Diagnostic probes and therapeutics targeting uPA and uPARANGSTROM PHARMACEUTICALS INC·Filed 2000·Granted May 24, 2005·9 cites·19 claims
- 0581US11510904B2Methods of treating malignant lymphoproliferative disordersACTUATE THERAPEUTICS INC·Filed 2019·Granted Nov 29, 2022·2 cites·24 claims
- 0681US7189865B2Thiomolybdate analogues and uses thereofUNIV MICHIGAN·Filed 2003·Granted Mar 13, 2007·22 cites·112 claims
- 0779US2024366563A1Methods of treating malignant lymphoproliferative disordersACTUATE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0877US8105602B2Urokinase-type plasminogen activator receptor epitope, monoclonal antibodies derived therefrom and methods of use thereofPARRY GRAHAM·Filed 2007·Granted Jan 31, 2012·5 cites·23 claims
- 0975US5994309AAnti-invasive and anti-angiogenic compositions and methodsANGSTROM PHARMACEUTICALS INC·Filed 1997·Granted Nov 30, 1999·26 cites·8 claims
- 1073US6936587B1Anti-invasive and anti-angiogenic compositionsANGSTROM PHARMACEUTICALS INC·Filed 2003·Granted Aug 30, 2005·3 cites·6 claims
- 1173US6277818B1Cyclic peptide ligands that target urokinase plasminogen activator receptorANGSTROM PHARMACEUTICALS INC·Filed 1998·Granted Aug 21, 2001·36 cites·60 claims
- 1267US2022409751A1Urokinase Plasminogen Activator Receptor-Targeted RadiopharmaceuticalNORTHSTAR MEDICAL TECH LLC·Filed 2022·Application pending·0 cites
- 1367US2022378956A1Trivalent Radioisotope Bio-Targeted Radiopharmaceutical, Methods Of Preparation And UseNORTHSTAR MEDICAL TECH LLC·Filed 2022·Application pending·0 cites
- 1464US2021251897A9Nanoparticle arsenic-platinum compositionsUNIV NORTHWESTERN·Filed 2019·Application pending·0 cites
- 1561US7119069B2Human kininogen D3 domain polypeptide as an anti-angiogenic and anti-tumor agentATTENUON LLC·Filed 2006·Granted Oct 10, 2006·0 cites·17 claims
- 1660US6696416B1Anti-invasive and anti-angiogenic compositionsANGSTROM PHARMACEUTICALS INC·Filed 1999·Granted Feb 24, 2004·11 cites·8 claims
- 1759US7851505B2Thiotungstate analogues and uses thereofATTENUON LLC·Filed 2004·Granted Dec 14, 2010·1 cites·15 claims
- 1858US7098187B2Human kininogen D3 domain polypeptide as an anti-angiogenic and anti-tumor agentATTENUON LLC·Filed 2003·Granted Aug 29, 2006·0 cites·17 claims
- 1955US7517855B2Peptides which inhibit angiogenesis, cell migration, cell invasion and cell proliferation, compositions and uses thereofATTENUON LLC·Filed 2003·Granted Apr 14, 2009·0 cites·9 claims
- 2055US2014220115A1Nanoparticle arsenic-platinum compositionsUNIV NORTHWESTERN·Filed 2014·Application pending·0 cites
- 2155US2011020434A1Nanoparticle arsenic-platinum compositionsO'HALLORAN THOMAS V·Filed 2010·Application pending·0 cites
- 2254US2003027768A1Anti-invasive and anti-angiogenic compositionsFiled 2002·Application pending·0 cites
- 2353US2009312243A1Treatment of inflammatory bowel disease (ibd) with anti-angiogenic compoundsDANESE SILVIO·Filed 2006·Application pending·0 cites
- 2453US2023062278A1Compounds for the treatment of myelofibrosisACTUATE THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2550US2023338590A1Materials and methods for treating coronavirusMONOPAR THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2649US2004204348A1Cyclic peptide ligands that target urokinase plasminogen activator receptorANGSTROM PHARMACEUTICALS INC·Filed 2003·Application pending·0 cites
- 2746US8110543B2Anti-invasive and anti-angiogenic compositionsMAZAR ANDREW P·Filed 2010·Granted Feb 7, 2012·0 cites·4 claims
- 2843US2005232924A1Antibodies and/or conjugates thereof which bind to the amino terminal fragment of urokinase, compositions and uses thereofATTENUON LLC·Filed 2004·Application pending·0 cites
- 2943US2009170123A1Identification of Novel Protein Targets on the Surface of Stressed CellsDONATE FERNANDO·Filed 2006·Application pending·0 cites
- 3042US2009264628A1Crystal structure of human urokinase plasminogen activator amino teminal fragment bound to its receptorBETH ISRAEL HOSPITAL·Filed 2006·Application pending·0 cites
- 3141US2008261892A1Acid Addition Salts of Ac-Phscn-Nh2TERNANSKY ROBERT J·Filed 2006·Application pending·0 cites
- 3240US2011151022A1Thiotungstate analogues and uses thereofATTENUON LLC·Filed 2010·Application pending·0 cites
- 3338US2005124794A1Cell surface tropomyosin as a target of angiogenesis inhibitionFiled 2003·Application pending·0 cites
- 3436US2003082740A1Histidine proline rich glycoprotein (HPRG) as an anti-angiogenic and anti-tumor agentFiled 2002·Application pending·0 cites
- 3534US2008031817A1Inhibition Of Superoxide Dismutase By Tetrathiomolybdate: Identification Of New Anti-Angiogenic And Antitumor AgentsMAZAR ANDREW P·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Andrew P. Mazar files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →